2021 News Release
-
NHI Drug Price Reform in Fiscal 2022
-
The 15th Survey on Sei-katsu-sha Attitudes Toward Drugs and the Pharmaceutical Industry
-
JPMA Code of Practice "Code Understanding Promotion Month
-
JPMA member company's "Non-Financial Information Disclosure List" (links) is newly added.
-
Disciplinary Action against a Member Company
-
The "Pharmaceutical Industry Vision 2021" is released.
-
JPMA Website Renewal Announcement
〜 The website is easy to use and the industry's voice is easily heard in order to strengthen information dissemination. -
Disciplinary Action against a Member Company
-
JPMA Chairman's Press Conference held on May 20
-
About the "JPMA Industry Vision 2025 Supplementary Edition
-
Election of New Board Members
-
On the Abandonment of Intellectual Property in the WTO
-
On the Occasion of the "10th Conference of the Association of Pharmaceutical Manufacturers in Asia
-
10th Asian Pharmaceutical Association Conference (APAC) Press Conference on April 14
-
JPMA Chairman's Press Conference held on March 23
-
National Center for Biobank Network and Japan Pharmaceutical Manufacturers Association Member Companies Launch Industry-Academia-Government Collaboration to Establish and Utilize Integrated Disease-Specific Information Database
Toward Early Implementation of Precision Medicine, Preventive and Preemptive Medicine -
Approaches to countermeasures against new coronavirus infection
In response to the declaration of a state of emergency